Insmed (INSM)

Adrestia Therapeutics Inc. • Celtrix Pharmaceuticals, Inc. • Insmed Gene Therapy LLC • Insmed Limited • Insmed Holdings Limited • Insmed Innovation UK Limited • Insmed Ireland Limited • Insmed Netherlands Holdings B.V. • Insmed Netherlands B.V. • Insmed Germany GmbH ...

IRS number

541972729

INSM stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$89.67

Low target

$83.00

High target

$100.00

Latest filings (excl ownership)

View all

8-K

Termination of a Material Definitive Agreement

19 Nov 24

8-K

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

31 Oct 24

Regulation FD Disclosure

3 Jul 24

8-K

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025

Regulation FD Disclosure

4 Jun 24

8-K

Insmed Announces Proposed $500 Million Public Offering of Common Stock

30 May 24

424B5

Prospectus supplement for primary offering

30 May 24

424B5

Prospectus supplement for primary offering

28 May 24

Transcripts

View all

INSM

Earnings call transcript

2024 Q3

31 Oct 24

INSM

Earnings call transcript

2024 Q2

8 Aug 24

INSM

Earnings call transcript

2024 Q1

9 May 24

INSM

Earnings call transcript

2023 Q4

22 Feb 24

INSM

Earnings call transcript

2023 Q3

26 Oct 23

INSM

Earnings call transcript

2023 Q2

3 Aug 23

INSM

Earnings call transcript

2023 Q2

3 Aug 23

INSM

Earnings call transcript

2023 Q1

4 May 23

INSM

Earnings call transcript

2023 Q1

4 May 23

INSM

Earnings call transcript

2022 Q4

23 Feb 23

Latest ownership filings

View all

William Lewis

20 Dec 24

144

Notice of proposed sale of securities

Notice of proposed sale of securities

12 Dec 24

SC 13G/A

PRICE T ROWE ASSOCIATES INC /MD/

14 Nov 24

Michael Alexander Smith

Notice of proposed sale of securities

13 Sep 24

Orlov S Nicole Schaeffer

10 Sep 24

144

Notice of proposed sale of securities

10 Sep 24

Financial summary

Financial statements Chart INSM financial data

Quarter (USD)	Sep 24	Mar 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	461.45 mm	461.45 mm	461.45 mm	461.45 mm	461.45 mm	461.45 mm
Cash burn (monthly)	44.76 mm	12.62 mm	73.17 mm	59.96 mm	(no burn)	35.83 mm
Cash used (since last report)	124.98 mm	35.24 mm	204.31 mm	167.41 mm	n/a	100.03 mm
Cash remaining	336.47 mm	426.22 mm	257.14 mm	294.04 mm	n/a	361.42 mm
Runway (months of cash)	7.5	33.8	3.5	4.9	n/a	10.1

Beta Read what these cash burn values mean

Financial data from Insmed earnings reports.

Institutional ownership, Q3 2024

INSM institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	412	388	+6.2%
Opened positions	72	128	-43.8%
Closed positions	48	35	+37.1%
Increased positions	181	132	+37.1%
Reduced positions	109	99	+10.1%

13F shares	Current	Prev Q	Change
Total value	11.99 tn	10.46 tn	+14.7%
Total shares	185.20 mm	183.70 mm	+0.8%
Total puts	3.33 mm	5.18 mm	-35.7%
Total calls	2.27 mm	5.79 mm	-60.8%
Total put/call ratio	1.5	0.9	+63.9%

Largest owners	Shares	Value	Change
Vanguard	17.14 mm	$1.25 tn	+7.1%
BLK BlackRock	14.97 mm	$1.09 tn	NEW
T. Rowe Price	12.58 mm	$918.41 mm	+3.4%
Darwin Global Management	10.50 mm	$766.30 bn	+196.4%
FMR	7.19 mm	$524.98 bn	-1.6%
Capital International Investors	6.52 mm	$476.24 bn	+11.1%
STT State Street	6.18 mm	$451.01 bn	+32.5%
Baker Bros. Advisors	4.42 mm	$322.36 bn	+23.5%
Geode Capital Management	3.81 mm	$278.43 bn	+4.7%
JPM JPMorgan Chase & Co.	3.31 mm	$241.36 bn	+13.0%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	14.97 mm	+14.97 mm	NEW
BLK BlackRock	0.00	-14.26 mm	EXIT
Lord, Abbett & Co.	1.47 mm	-7.66 mm	-83.9%
Darwin Global Management	10.50 mm	+6.96 mm	+196.4%
Deep Track Capital	0.00	-2.00 mm	EXIT
Norges Bank	0.00	-1.76 mm	EXIT
STT State Street	6.18 mm	+1.52 mm	+32.5%
Vanguard	17.14 mm	+1.13 mm	+7.1%
William Blair Investment Management	2.42 mm	-1.05 mm	-30.2%
Viking Global Investors	0.00	-1.04 mm	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

INSM insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
19 Dec 24	William Lewis	Common Stock	Sell	Dispose S	Yes	Yes	70.61	1,590	112.27 k	233,924
19 Dec 24	William Lewis	Common Stock	Sell	Dispose S	Yes	Yes	69.71	5,240	365.28 k	235,514
19 Dec 24	William Lewis	Common Stock	Option exercise	Acquire M	Yes	Yes	10.85	6,830	74.11 k	240,754
19 Dec 24	William Lewis	Common Stock	Sell	Dispose S	No	Yes	70.52	5,588	394.07 k	384,960
19 Dec 24	William Lewis	Common Stock	Sell	Dispose S	No	Yes	69.65	13,162	916.73 k	390,548
19 Dec 24	William Lewis	Common Stock	Option exercise	Acquire M	No	Yes	22.76	18,750	426.75 k	403,710
19 Dec 24	William Lewis	Stock Option Common Stock	Option exercise	Dispose M	Yes	Yes	10.85	6,830	74.11 k	232,290
19 Dec 24	William Lewis	Stock Option Common Stock	Option exercise	Dispose M	No	Yes	22.76	18,750	426.75 k	112,500
12 Dec 24	William Lewis	Common Stock	Sell	Dispose S	Yes	Yes	74.22	181	13.43 k	233,924
12 Dec 24	William Lewis	Common Stock	Sell	Dispose S	Yes	Yes	73.55	2,562	188.44 k	234,105